🔎 Trials Near Me

Utama › Sistem Imun dan Gangguan › New Jersey

Kajian klinikal Sistem Imun dan Gangguan di New Jersey

6 kajian untuk Sistem Imun dan Gangguan sedang mencari peserta di lokasi di New Jersey.

Bandar di New Jersey

Teks kajian rasmi (Bahasa Inggeris)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07192471

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Englewood Hospital and Medical Center, Englewood
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04242095

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • American Oncology Partners of Maryland, PA, Morristown
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07075185

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05826535

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.